| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 228 |
| 1 | ASPIRIN | 135 |
| 2 | ASPIRIN 325 MG | 119 |
| 3 | ASPIRIN 81 MG | 119 |
| 4 | ATORVASTATIN CALCIUM | 102 |
| 5 | CLOPIDOGREL | 87 |
| 6 | OMEPRAZOLE MAGNESIUM | 84 |
| 7 | SIMVASTATIN | 83 |
| 8 | FUROSEMIDE | 78 |
| 9 | OMEPRAZOLE | 74 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | THROMBIN TOPICAL RECOMBINANT | 8 | 0.1176 |
| 1 | AMPICILLIN SODIUM, SULBACTAM SODIUM | 1 | 0.0263 |
| 2 | BENZYL ALCOHOL | 1 | 0.0095 |
| 3 | ASPRIN AND CAFFEINE | 1 | 0.0082 |
| 4 | CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE | 18 | 0.0069 |
| 5 | ETOPOSIDE PHOSPHATE | 5 | 0.0031 |
| 6 | THROMBIN HUMAN AND FIBRINOGEN | 1 | 0.0030 |
| 7 | SARGRAMOSTIM | 5 | 0.0029 |
| 8 | CLEVIDIPINE | 1 | 0.0027 |
| 9 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 34 | 0.0025 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 210 |
| 1 | Corticosteroid [EPC] | 146 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 139 |
| 3 | Angiotensin 2 Receptor Blocker [EPC] | 130 |
| 4 | beta-Adrenergic Blocker [EPC] | 119 |
| 5 | HMG-CoA Reductase Inhibitor [EPC] | 113 |
| 6 | Proton Pump Inhibitor [EPC] | 108 |
| 7 | Thiazide Diuretic [EPC] | 95 |
| 8 | Insulin Analog [EPC] | 93 |
| 9 | P2Y12 Platelet Inhibitor [EPC] | 88 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 2 | 0.0018 |
| 1 | Vitamin D2 Analog [EPC] | 9 | 0.0013 |
| 2 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 3 | Opioid Antagonist [EPC] | 1 | 0.0010 |
| 4 | Phosphodiesterase 3 Inhibitor [EPC] | 6 | 0.0010 |
| 5 | P2Y12 Platelet Inhibitor [EPC] | 88 | 0.0007 |
| 6 | Calcitonin [EPC] | 2 | 0.0006 |
| 7 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 2 | 0.0006 |
| 8 | Vitamin D Analog [EPC] | 10 | 0.0006 |
| 9 | Photoenhancer [EPC] | 2 | 0.0005 |